Cilian AG is an innovative biotechnology enterprise that leverages the unique abilities of Ciliates, a new class of production organisms, for the industrial production of therapeutic proteins. The company operates as a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO), specialising in the production of vaccines, monoclonal antibodies, and other biopharmaceuticals.

Services include:
- Production of therapeutic proteins
- Development and production of vaccines
- Manufacturing of monoclonal antibodies
- Process development and optimisation
- Quality control and assurance
- Regulatory support and consulting

Cilian is dedicated to advancing biopharmaceutical production through its unique capabilities, ensuring high-quality and efficient manufacturing solutions for the pharmaceutical industry. For more information, please visit cilian.de.